Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-04 | FENNEC PHARMACEUTICALS INC. | Raykov Rosty
(Director) |
S | Common shares | D | 2431 | $4.31 - $4.31 | $10,477 |
| 2024-10-31 | FENNEC PHARMACEUTICALS INC. | Raykov Rosty
(Director) |
A | Common shares | A | 2431 | $0.00 - $0.00 | $0 |
| 2024-10-31 | FENNEC PHARMACEUTICALS INC. | Andrade Robert
(CHIEF FINANCIAL OFFICER) |
A | Common shares | A | 1042 | $0.00 - $0.00 | $0 |
| 2024-10-08 | FENNEC PHARMACEUTICALS INC. | RALLIS CHRIS A
(Director) |
S | Common Shares | D | 1406 | $4.53 - $4.53 | $6,369 |
| 2024-10-08 | FENNEC PHARMACEUTICALS INC. | RALLIS CHRIS A
(Director) |
M | Common Shares | A | 1960 | $2.55 - $2.55 | $4,998 |
| 2024-08-23 | FENNEC PHARMACEUTICALS INC. | Raykov Rosty
(Director) |
G | Common shares | D | 121039 | $0.00 - $0.00 | $0 |
| 2024-08-23 | FENNEC PHARMACEUTICALS INC. | Raykov Rosty
(Director) |
G | Common shares | D | 95038 | $0.00 - $0.00 | $0 |
| 2024-08-01 | FENNEC PHARMACEUTICALS INC. | Raykov Rosty
(CHIEF EXECUTIVE OFFICER) |
S | Common shares | D | 2431 | $6.25 - $6.25 | $15,205 |
| 2024-07-31 | FENNEC PHARMACEUTICALS INC. | Raykov Rosty
(CHIEF EXECUTIVE OFFICER) |
A | Common shares | A | 2431 | $0.00 - $0.00 | $0 |
| 2024-07-02 | FENNEC PHARMACEUTICALS INC. | Raykov Rosty
(CHIEF EXECUTIVE OFFICER) |
S | Common shares | D | 2431 | $6.13 - $6.13 | $14,902 |
| 2024-07-01 | FENNEC PHARMACEUTICALS INC. | Raykov Rosty
(CHIEF EXECUTIVE OFFICER) |
A | Common shares | A | 2431 | $0.00 - $0.00 | $0 |
| 2024-07-01 | FENNEC PHARMACEUTICALS INC. | Andrade Robert
(CHIEF FINANCIAL OFFICER) |
A | Common shares | A | 1042 | $0.00 - $0.00 | $0 |
| 2024-05-31 | FENNEC PHARMACEUTICALS INC. | Andrade Robert
(CHIEF FINANCIAL OFFICER) |
A | Common shares | A | 1042 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |